For citations:
Erdes Sh., Mazurov V.I., Gaydukova I.Z., Anoshenkova O.N., Vinogradova I.B., Grabovetskaya Yu.Yu., Davidian S.Yu., Epifanova O.E., Kiryukhina N.A., Masneva L.V., Menshikova I.V., Mironenko O.N., Nikulenkova N.E., Povarova T.V., Polyatika A.N., Samigullina R.R., Sizikov A.E., Totrov I.N., Umnova I.F., Usacheva J.V., Chudinov A.L. Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: First year results of the LIBRA post-registration safety study. Rheumatology Science and Practice. 2023;61(6):700-710. (In Russ.) https://doi.org/10.47360/1995-4484-2023-700-710
Email this article 